Cinnarizin. 25 mg. 50 tablets

What is in your medicine?
Each tablet contains Cinnarizin-Pharma drug 25 mg Cinnarizine (cinnarizine) .Lekarstvoto contains as inactive ingredients: lactose monohydrate, corn starch, colloidal anhydrous silica, magnesium stearate, povidone K 25 and Talk.Lekarstvena form and Pharmacotherapeutic grupaTsinarizin-Pharma tablets belongs to the group of vehicles and antivertigenoznite improves cerebral circulation.
 
  Why use this medicine?
Cinnarizin-Pharma is intended for maintenance treatment of symptoms of labyrinth disorders such as vertigo, tinnitus, nystagmus, nausea and vomiting. Prevention of kinetoses.
 
 
How to take your medicine?
Cinnarizin-Pharma 25 mg tablets is intended for vazrastni.Pri labyrinth disorders taken 1 tablet 3 times dnevno.Kinetozi: 1 tablet half an hour before travel, if necessary, the dose may be repeated every 6 chasa.Maksimalnata daily dose is 6 tablets.
 
Method of administration:
The tablets are taken by mouth with plenty of water (eg. Glass of water) during or immediately after a meal.
 
Attention! When should not use this medicine?
Cinnarizin-Pharma should not be used in the following cases:
• If you are hypersensitive to the active substance and / or any of the excipients of the product.
• If you suffer from motor disorders (movement disorders) in the presence of tremor (shaking) or extrapyramidal disorders (diseases with multiple appearances of the central nervous system) and Parkinson's disease;
 
• If you suffer from depression (anxiety), angle-closure glaucoma (increased intraocular pressure), urinary retention associated with uretroprostatni disorders (difficulty in urination).
• If you suffer from hypotension (decreased blood pressure).
 
Special precautions for use
• At the beginning of treatment in individual patients can be observed intensification of treatment (therapeutic) effect of the product, which can be expressed by dizziness, and lower blood pressure.
• Note that in the elderly can lead to chronic constipation risk of paralytic ileus (bowel obstruction) and to strengthen the manifestations (symptoms) in prostatic hypertrophy (enlarged prostate gland).
• In severe hepatic and / or renal failure have an increased risk of accumulation (accumulation) of the medicinal product.
 
What should be paid attention during pregnancy and lactation?
Pregnancy: It is advisable to avoid taking Cinnarizin-Pharma during pregnancy. If you know you are pregnant while taking the medicine, consult your doctor, who can only
Lactation: During Breastfeeding adoption of Cinnarizin-Pharma should be avoided.
 
 
  What is the impact of the drug on the ability to drive and use machines?
Individual patients Cinnarizin may affect alertness and reflexes, and therefore should be used with caution in drivers of motor vehicles operating on high and machines due to delayed reactions especially in early treatment.
Important information about some of the ingredients of Cinnarizin-Pharma
This medicine contains lactose and wheat nisheste.Laktozata may be dangerous for people with lactase deficiency, galactosemia or glucose / galactose malabsorption syndrome (a disorder in digestion and absorption of substances in the small intestine). Wheat starch, which can be dangerous for people with celiac disease (gluten intolerance) .What interactions occur between Cinnarizin-Pharma and other drugs * are being treated? Caution should be exercised when co-administration of Cinnarizin-Pharma and drugs the following groups:
• analgesics, hypnotics, anesthetic agents, alcohol, due to the possibility cinnarizine enhance their inhibitory effect on the central nervous system (CNS).
• Cinnarizine as a means of antihistamine action may increase the sedative (calming) effect of these depressants (suppressing) CNS agents such as alcohol, barbiturates (phenobarbital, hypnotics (sleeping pills), opioid analgesics (codeine), anxiolytics and neuroleptics (diazepam).
• No adverse interactions Cinnarizine when used concomitantly with antihypertensive (blood pressure lowering agents), diuretics (water resources), anticoagulants (anticoagulants) or hypoglycemic drugs (lowering blood sugar).
• With atropine and other anticholinergic (antispasmodic painkillers) funds can be expected additive (complementary) effect.
• If you are conducting a test to determine skin reactivity, stop taking the therapeutic product four days before the study, due to the risk of false negative results.
 
What side effects may occur in the application of Cinnarizin Pharma?
  Medicine, as a rule, are well accepted by patients. But like any other drug, Cinnarizin-Pharma in some cases can cause side effects of varying severity in some patients:
• At the beginning of treatment may occur drowsiness, dizziness, discomfort in the abdomen. These signs do not require discontinuation of treatment.
• may rarely occur skin rashes, itching, drowsiness, nausea, vomiting, insomnia, depression, dry mouth.
• With prolonged treatment in elderly patients Cinnarizin can cause disturbances in motor activity, in some cases the occurrence of tremors, increased muscle tone.
• For long-term treatment with the medicine risk of increasing body teglo.V these and all other cases, including listed in the instruction, need immediate consultation with your doctor.
What to do if you take more than Cinnarizin-Pharma need?
If you accidentally take a significantly higher dose than prescribed and signs of drowsiness, vomiting, muscle weakness, tremors, it is necessary to immediately seek medical attention.
What to do if you forget to take Cinnarizin-Pharma?
Do not take a double dose to make up for a missed dose. Take your next dose at the usual time.
 
How should STORE Cinnarizin-Pharma?
• Do not store above 25 ° C!
• Keep out of reach of children!
• Protect from light and moisture!
  
Expiration date
• The expiry date is marked out on the carton and blister.
• If stored correctly, the shelf life is three years from the date of manufacture.
• Cinnarizin-Pharma should not be used after the expiry date.
 
Method of otpuskaneOtpuska without a prescription.
 
Packaging Data
• The tablets are packaged in blister packs of rigid PVC film and aluminum foil. • Tablets 25 mg 50 pieces in one pack (1 piece blister).